Back to company

Inter Biosolutions ApS: Financial statements 2022

CVR: 43014757

Inter Biosolutions ApS (CVR 43014757) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 0 and a net result of DKK -8,311. Equity amounted to DKK 33,689. The solvency ratio was 24.8%.

Revenue
0 kr.
Gross Profit
-8,170 kr.
Profit/Loss
-8,311 kr.
Equity
33,689 kr.
Total Assets
135,736 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Inter Biosolutions ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Inter Biosolutions ApS appoints new auditorJan 26, 2022

As of January 26, 2022, MARTINSEN STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Inter Biosolutions ApS.

Carsten Pedersen Rise joins Inter Biosolutions ApS as directorJan 26, 2022

As of January 26, 2022, Carsten Pedersen Rise is registered as director of Inter Biosolutions ApS.

Inter Biosolutions ApS is foundedJan 26, 2022

Inter Biosolutions ApS was founded on January 26, 2022.

About Inter Biosolutions ApS

Inter Biosolutions ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Inter Biofuel ApS. The management consists of Klaus Hjortenberg Kroll. The company is owned by STEEN BRUMMERSTEDT IVERSEN ApS and Kobo ApS. In 2025, the company reported a gross profit of DKK 1,732,251 and a net result of DKK -1,516,000 compared with DKK -485,946 the year before. Equity amounted to DKK 1,017,129.

Other financial years